Skip to content

Trials of fetoscopic laser surgery for Monochorionic twin pregnancy with severe selective intarauterine growth restriction

Trials of fetoscopic laser surgery for Monochorionic twin pregnancy with severe selective intarauterine growth restriction - Fetoscopic laser surgery for SIUGR

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000007000
Enrollment
10
Registered
2012-01-01
Start date
2011-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Monochorionic twin pregnancy with severe selective intarauterine growth restriction

Interventions

Sponsors

Japan Fetal Therapy Group (Fetus Japan)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Between 20 weeks and 24 weeks gestation 2) Monochorionic diamniotic twin pregnancy 3) Ultrasound findings within four days before surgery meet the criteria as described following I) Estimated fetal weight is less than -1.5SD in one twin II) not TTTS (MVP>2cm in one twin, and MVP<8cm in another twin and not TAFD(MVP<3cm in one twin and MVP>7cm in another twin) III) The presence of severe oligohydramnios defined by less than 1cm of MVP in a smaller twin IV) Presence of abnormal Doppler study in a smaller twin 4) No history of amnioreduction 5) No presence of fetal anomalies 6) No sign of pregnancy induced hypertension 7) No genital bleeding 8) No premature rupture of membrane 9) Greater than or equal to 20mm of Cervical length

Exclusion criteria

Exclusion criteria: 1) Distance between expected insertion site of fetoscopy and the edge of placenta is below 1 cm. 2) Pregnant woman needs treatment for infectious disease. 3) Presence of HIV antibody, HCV antibody, or HBe antigen in pregnant women 4) Pregnant woman needs treatment for psychological problems 5) American Society of Anesthesiology (ASA) Physical Status Classification: Class 3, 4, 5, or 6

Design outcomes

Primary

MeasureTime frame
Completion of laser surgery and safety for pregnant women

Secondary

MeasureTime frame
Improvement of SIUGR at 14 days after surgery, incidence of TTTS or 14 days after surgery, Complications of laser surgery until 14 days after laser surgery

Countries

Japan

Contacts

Public ContactKeisuke Ishii MD Ph D

Osaka Medical Center and Research Institute for Maternal and Child Health Department of Maternal-Fetal Medicine

keisui@mch.pref.osaka.jp81725561220

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026